In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.

New Regulatory Measures for Valproate



The Chief Medical Officer, Dr Frank Atherton, has written to all healthcare professionals in Wales to advise them of the changes and his expectation of the actions they are required to take.  

A pdf copy of the CMO’s letter to healthcare professionals in Wales can be accessed directly HERE
MHRA has also included details in the Drug Safety Update.  Please see here for a copy of the Drug Safety Update.
The valproate web page on MHRA’s GOV.UK website will be updated with copies of the new guides once these become available.
The MHRA have also issued a  Press Release outlining the strengthened regulatory measures and advising of their implementation over the coming period.